Emerging macrolide resistance in Mycoplasma genitalium

Lancet Infect Dis. 2020 Nov;20(11):1222-1223. doi: 10.1016/S1473-3099(20)30462-X. Epub 2020 Jul 2.

Authors

Piet Cools¹, Elizaveta Padalko²

Affiliations

¹ Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Laboratory of Medical Microbiology, Ghent University Hospital, Ghent B-9000, Belgium.
² Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Laboratory of Medical Microbiology, Ghent University Hospital, Ghent B-9000, Belgium. Electronic address: elizaveta.padalko@uzgent.be.

PMID: 32622379
DOI: 10.1016/S1473-3099(20)30462-X

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Drug Resistance, Bacterial / drug effects
Fluoroquinolones
Humans
Macrolides / pharmacology
Mutation
Mycoplasma genitalium* / genetics
Prevalence

Substances

Anti-Bacterial Agents
Fluoroquinolones
Macrolides